Reuters logo
J&J's quarterly sales rise 1.6 pct
April 18, 2017 / 10:53 AM / 5 months ago

J&J's quarterly sales rise 1.6 pct

April 18 (Reuters) - Johnson & Johnson, which is in the process of completing its $30 billion acquisition of Swiss biotech Actelion, reported on Tuesday a 1.6 percent rise in first-quarter sales.

The diversified healthcare company’s sales rose to $17.77 billion in the first quarter from $17.48 billion a year earlier.

J&J’s net earnings in the quarter were $4.42 billion, or $1.61 per share. The company reported net earnings of $4.46 billion, or $1.59 per share, a year ago. (Reporting by Natalie Grover in Bengaluru; Editing by Martina D‘Couto)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below